Windsor, CT (PRWEB) August 27, 2004 -
Protedyne Corporation, a leading laboratory automation supplier, today announced that Dr. Anthony Martin will join the companyÂs board of directors.
Dr. Martin was formerly chairman, president and CEO of Molecular Probes Inc, a worldwide provider of fluorescence-based detection products and solutions that advance biomedical and other scientific research. At Molecular Probes, Dr. Martin was responsible for setting the companyÂs business strategy and increased profits by 20% per year. The strengthening of the company led to its successful acquisition by Invitrogen, where Dr. Martin had served as president of the Molecular Biology division.
ÂI am greatly impressed by what Protedyne is bringing to our industry,Â said Dr. Martin. ÂThe BioCubeÂ System is changing how laboratories use automation, and IÂm excited to be part of the future of this dynamic company."
ÂOne of my goals was to add experienced leaders to our board of directors,Â commented Don Schoeny, president of Protedyne. ÂI feel most fortunate to have Tony Martin, a global veteran in biotechnology, agree to sit on our board. ProtedyneÂs growth this year has been astounding. To have an industry leader of TonyÂs caliber place his confidence in Protedyne speaks to the bright future of this company.Â
ProtedyneÂs unique approach combines scientific and automation expertise, industrial-quality automation and sophisticated data management. The foundation of the company is the BioCube System, which brings advanced industrial automation capabilities into life science and diagnostic laboratories in a fast, flexible, and reliable package. Protedyne is headquartered in Windsor, CT. For more information, call (860) 683-1860 in North America or visit Protedyne on the web at http://www.protedyne.com
# # #